Corvus Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CRVS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
06 May 24	BuyUS$34,624	William Jones	Individual		20,000	US$1.73
06 May 24	BuyUS$1,000,000	Richard Miller	Individual		577,634	US$1.73

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRVS?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,211,954	3.44%
Institutions	9,785,793	15.2%
Hedge Funds	10,103,088	15.7%
VC/PE Firms	10,219,270	15.9%
General Public	31,937,146	49.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31%.

Top Shareholders

Top 25 shareholders own 48.65% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.8%	OrbiMed Advisors LLC	6,943,654	US$36.7m	0%	0.49%
8.67%	Point72 Asset Management, L.P.	5,572,755	US$29.5m	-6.95%	0.07%
7.05%	Samlyn Capital, LLC	4,530,333	US$24.0m	-26%	0.35%
5.1%	Adams Street Partners, LLC	3,275,616	US$17.3m	0%	15.34%
3.77%	The Vanguard Group, Inc.	2,420,619	US$12.8m	46.7%	no data
2.75%	Richard Miller	1,765,737	US$9.3m	0%	no data
2.33%	Vivo Capital, LLC	1,497,268	US$7.9m	0%	0.63%
0.94%	BlackRock, Inc.	603,877	US$3.2m	7.45%	no data
0.88%	Geode Capital Management, LLC	563,009	US$3.0m	22.4%	no data
0.78%	Ghost Tree Capital, LLC	500,000	US$2.6m	0%	0.96%
0.61%	Morgan Stanley, Investment Banking and Brokerage Investments	393,262	US$2.1m	5.89%	no data
0.6%	Renaissance Technologies LLC	386,588	US$2.0m	-31.5%	no data
0.59%	Goldman Sachs Group, Investment Banking and Securities Investments	376,121	US$2.0m	0%	no data
0.52%	Schonfeld Strategic Advisors LLC	331,360	US$1.8m	0%	0.01%
0.5%	Marshall Wace LLP	323,211	US$1.7m	334%	no data
0.48%	Millennium Management LLC	311,288	US$1.6m	52.2%	no data
0.44%	Leiv Lea	282,444	US$1.5m	0%	no data
0.34%	Susquehanna International Group, LLP, Asset Management Arm	218,962	US$1.2m	754%	no data
0.28%	State Street Global Advisors, Inc.	178,246	US$942.9k	48.2%	no data
0.24%	William Jones	153,773	US$813.5k	0%	no data
0.21%	Connor, Clark & Lunn Investment Management Ltd.	137,031	US$724.9k	64.7%	no data
0.2%	Qube Research & Technologies Ltd	127,332	US$673.6k	0%	no data
0.2%	Bridgeway Capital Management, LLC	127,300	US$673.4k	0%	0.01%
0.19%	Citigroup Inc.,Banking and Securities Investments	122,858	US$649.9k	0%	no data
0.18%	TowerView LLC	117,500	US$621.6k	-70.6%	0.4%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 14:38
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Corvus Pharmaceuticals, Inc. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Dane Leone	BTIG
Li Wang Watsek	Cantor Fitzgerald & Co.
Vamil Divan	Credit Suisse